Literature DB >> 23629644

Chronic kidney disease: How effective and safe are antiplatelet agents in CKD?

Jürgen Floege1, Georg Schlieper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23629644     DOI： 10.1038/nrneph.2013.83

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  8 in total

Review 1.  Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification?

Authors:  Thilo Krueger; Ralf Westenfeld; Markus Ketteler; Leon J Schurgers; Jürgen Floege
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

2.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Authors:  Ron Pisters; Deirdre A Lane; Robby Nieuwlaat; Cees B de Vos; Harry J G M Crijns; Gregory Y H Lip
Journal:  Chest       Date:  2010-03-18       Impact factor: 9.410

Review 3.  Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis.

Authors:  Suetonia C Palmer; Lucia Di Micco; Mona Razavian; Jonathan C Craig; Pietro Ravani; Vlado Perkovic; Gianni Tognoni; Giusi Graziano; Meg Jardine; Fabio Pellegrini; Antonio Nicolucci; Angela Webster; Giovanni F M Strippoli
Journal:  Am J Kidney Dis       Date:  2012-09-28       Impact factor: 8.860

Review 4.  Management of cardiovascular disease in patients with kidney disease.

Authors:  Mark R Kahn; Michael J Robbins; Michael C Kim; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2013-02-19       Impact factor: 32.419

5.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

Review 6.  Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates.

Authors:  Swapnil Hiremath; Rachel M Holden; Dean Fergusson; Deborah L Zimmerman
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 8.237

7.  Acute myocardial infarction and renal dysfunction: a high-risk combination.

Authors:  R Scott Wright; Guy S Reeder; Charles A Herzog; Robert C Albright; Brent A Williams; David L Dvorak; Wayne L Miller; Joseph G Murphy; Stephen L Kopecky; Allan S Jaffe
Journal:  Ann Intern Med       Date:  2002-10-01       Impact factor: 25.391

Review 8.  Antiplatelet agents for chronic kidney disease.

Authors:  Suetonia C Palmer; Lucia Di Micco; Mona Razavian; Jonathan C Craig; Vlado Perkovic; Fabio Pellegrini; Meg J Jardine; Angela C Webster; Sophia Zoungas; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
  8 in total
  2 in total

Review 1.  Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy.

Authors:  Constance C F M J Baaten; Jonas R Schröer; Jürgen Floege; Nikolaus Marx; Joachim Jankowski; Martin Berger; Heidi Noels
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-08       Impact factor: 8.237

Review 2.  The effect of aspirin on kidney allograft outcomes; a short review to current studies.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Donald G Mitema; Michael A Mao; Ankit Sakhuja; Wonngarm Kittanamongkolchai; Maria L Gonzalez-Suarez; Stephen B Erickson
Journal:  J Nephropathol       Date:  2017-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.